SANTA MONICA, CA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Oliveda International, Inc. (OTC Pink: OLVI), a leading international natural cosmetics innovator whose products deliver higher efficiency than other brands, today announced the successful roll-out of what is expected to become one of the brand’s best-selling products, The Beauty Fountain, a daily anti-wrinkle Collagen Hydroxytyrosol drink. Taken internally as a daily 17.5 ml “shot,” The Beauty Fountain was initially introduced in Oliveda’s two German flagship stores, in Dusseldorf and Berlin, and online at https://www.oliveda.com/The-Beauty-Fountain_1 in late August 2018.
This launch is part of Oliveda International’s strategic global expansion, which is expected to include new products highly sought-after by consumers. This beauty shot – like all Oliveda products – harnesses the power of the olive tree as its base, rather than water. In addition to the Oliveda website, posts with pictures related to The Beauty Fountain can be found on Instagram at https://www.instagram.com/olivedaofficial/, Facebook at https://www.facebook.com/OlivedaCosmetics, and other Oliveda Deutschland channels.
The Beauty Fountain provides perfect cell protection and prevents the natural degradation of the beauty molecules hyaluron and collagen. Research has indicated that oral intake of bioactive collagen peptides delivers up to 65% more collagen content in the skin and results in up to 50% fewer wrinkles around the eyes. A separate study found that collagen peptides significantly reduce cellulite after just 3 months. The Beauty Fountain also delivers more porous, rosier and firmer skin as well as healthier and stronger fingernails.
A growing body of evidence suggests collagen can improve skin, ease arthritis symptoms, promote wound healing, and fend off muscle wasting. Consumers in the U.S. are expected to spend $122 million on collagen products in 2018, and increase of 30% over 2017.
Even more significantly, several recent studies have shown ingestible collagen to be a more effective method of impacting the skin.
“Since its introduction just a few weeks ago, The Beauty Fountain has been extremely well-received by our customers, and we believe it will be yet another product that elevates the growing reputation of our brand and increases revenues,” said OLVI Chairman and CEO Thomas Lommel.
“In The Beauty Fountain, we combine Hydroxytyrosol with bioactive collagen peptides, which counteract the natural degradation process of hyaluronic acid and collagen in the cells. At the same time, it is intended to stimulate new production in such a way that up to 60% more collagen in the skin is detected after only 30 days of intake. No skin cream in the world can do what The Beauty Fountain can in the interior of the body.”
Oliveda Deutschland’s current retail presence includes just 3 countries: Germany, Austria, and Switzerland. Additional Oliveda subsidiaries are planned for Europe, Asia, North America, and South America, which are expected to become part of the global Oliveda International footprint. Oliveda’s expansion strategy includes plans to open 60 worldwide stores the coming years.
The Oliveda story began with healing and the development of its first products in a tree house in the Andalusia region of Spain. Its products immediately captured the attention of those who were introduced to them. Now, with over 20 years of manufacturing and distribution of cosmetic and holistic products built around the pure essence of the olive tree and its oils, Oliveda Deutschland offers a complete line of products that includes face, body, hair, and products for inside-the-body holistic benefits.
Oliveda possesses 20 years of experience with organic, active substance cosmetics from the olive tree but has only been selling its products for eight years. Before that, the company developed, tested and applied the products in our exclusive Oliveda Spa in Mallorca. Then, when the first celebrities visited Oliveda’s spas and used the olive tree therapy, and Vogue and many other magazines reported on the uniqueness of Oliveda products, the company began serving markets in Germany, Austria, and Switzerland. Only now that Oliveda has secured the resources with more than 30,000 ecologically certified mountain olive trees does management feel ready to implement its business plan to grow to be able to act globally.
Additional information on the company’s current activities and future plans are expected to be disclosed in upcoming press release and filings. Interested investors are encouraged to contact the company at 619-202-7456 or investors@oliveda.com.
Oliveda International Inc.
Oliveda International, Inc. is a leading international natural cosmetic and wearable technology company founded by German real estate investor Thomas Lommel in 2003. In addition to online sales, the company’s Olive Tree Pharmacy store concept currently operates in Berlin and Dusseldorf, with stores in Los Angeles and Taipei expected to open by the end of 2018. Overall, the company believes it is positioned to operate 60 stores around the world within the next 5 years. For more information on Oliveda International, please visit http://www.oliveda.com.
Forward-Looking Statements
This press release may contain statements, estimates or projections that constitute "forward-looking statements" pursuant to the safe harbor provisions of the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties, which may be found in the Company’s filings with OTC Markets Group Inc., that could cause actual results to differ materially from the Company's historical experience and present expectations or projections. Investors should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Company expressly disclaims any obligation or intention to publicly update or revise any forward-looking statements unless otherwise required by law.